The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zai Lab Limited(NASDAQ:ZLAB) 
Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops, and commercializes therapeutics to treat oncology, autoimmune, and infectious diseases in China. The company offers ZEJULA for the treatment of breast cancer and non-small cell lung cancer (NSCLC); and Optune, a cancer ther...
Website: http://www.zailaboratory.com
Founded: 2013
Full Time Employees: 859
Sector: Healthcare
Industry: Biotechnology
Zai Lab Days Payable Outstanding ttm (DPO)
Zai Lab Days Receivable Outstanding ttm (DSO)
Zai Lab Days Inventory Outstanding ttm (DIO)
Zai Lab Op Cashflow Per Share ttm
Zai Lab Free Cashflow Per Share ttm
Zai Lab Cash Per Share ttm
Zai Lab P/S ratio ttm
Zai Lab (GAAP) P/E ratio ttm
Zai Lab P/B ratio ttm
No extra charts and metrics for this ticker.